Skip to main content
Premium Trial:

Request an Annual Quote

Biosearch Licenses Single-Molecule Fish Technology from UMDNJ

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biosearch Technologies announced today it has exclusively licensed a single-molecule fluorescent in situ hybridization technology from the University of Medicine and Dentistry of New Jersey.

Biosearch gained the exclusive rights to manufacture, catalogue, and sell validated RNA FISH probes, assays, and kits in the research, applied markets, and in vitro diagnostic fields under the UMDNJ technologies and patents applications. Terms of the agreement were not disclosed.

In a statement, Marc Beal, director of corporate development for Biosearch, said that his company's expertise in fluorescence and fluorescent oligonucleotide manufacturing coupled with the technology licensed from UMDNJ "will allow Biosearch to quickly penetrate the marketplace with both assays and kits."

Headquartered in Novato, Calif., Biosearch synthesizes oligonucleotides. The company also offers fluorogenic probes and primers, DNA and RNA synthesis reagents, and other materials for genomic research.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.